We are live on ! Find out more
PTX

Pernix Therapeutics Holdings, Inc.
PTX

Delisted

PTX was delisted on the 4th of March, 2019.

97 hedge funds and large institutions have $310M invested in Pernix Therapeutics Holdings, Inc. in 2014 Q4 according to their latest regulatory filings, with 26 funds opening new positions, 37 increasing their positions, 23 reducing their positions, and 10 closing their positions.

New
Increased
Maintained
Reduced
Closed

200% more funds holding in top 10

Funds holding in top 10: 26 (+4)

160% more first-time investments, than exits

New positions opened: 26 | Existing positions closed: 10

61% more repeat investments, than reductions

Existing positions increased: 37 | Existing positions reduced: 23

54% more capital invested

Capital invested by funds: $202M → $310M (+$109M)

17% more funds holding

Funds holding: 8397 (+14)

66% less call options, than puts

Call options by funds: $819K | Put options by funds: $2.38M

Holders
97
Holders Change
+14
Holders Change %
+16.87%
% of All Funds
2.59%
Holding in Top 10
6
Holding in Top 10 Change
+4
Holding in Top 10 Change %
+200%
% of All Funds
0.16%
New
26
Increased
37
Reduced
23
Closed
10
Calls
$819K
Puts
$2.38M
Net Calls
-$1.56M
Net Calls Change
-$540K
Name Holding Trade Value Shares
Change
Change in
Stake
EMR
26
Errol M. Rudman
$2.82M +$1.91M +20,000 +200%
TCM
27
Timpani Capital Management
Wisconsin
$2.74M +$2.78M +29,138 New
AQR Capital Management
28
AQR Capital Management
Connecticut
$2.49M -$50.9K -534 -2%
Bank of New York Mellon
29
Bank of New York Mellon
New York
$2.08M +$637K +6,675 +43%
TCIM
30
TIAA CREF Investment Management
New York
$2.06M -$29K -304 -1%
Dimensional Fund Advisors
31
Dimensional Fund Advisors
Texas
$2.06M
DCM
32
Driehaus Capital Management
Illinois
$2.02M +$1.92M +20,087 +1,383%
RFC
33
Russell Frank Company
Washington
$1.77M +$971K +10,178 +119%
Ameriprise
34
Ameriprise
Minnesota
$1.63M +$1.66M +17,355 +173,550%
CCM
35
Century Capital Management
Massachusetts
$1.62M +$1.65M +17,260 New
Geode Capital Management
36
Geode Capital Management
Massachusetts
$1.47M +$183K +1,917 +14%
TDC
37
Thompson Davis & Co
Virginia
$1.45M -$1.16M -12,187 -44%
Millennium Management
38
Millennium Management
New York
$1.4M -$1.31M -13,681 -48%
CCM
39
Coe Capital Management
Illinois
$1.31M +$1.33M +13,968 New
EIM
40
Essex Investment Management
Massachusetts
$1.27M +$351K +3,675 +37%
JAM
41
JW Asset Management
Florida
$1.05M +$1.07M +11,216 New
Citadel Advisors
42
Citadel Advisors
Florida
$1.05M +$962K +10,087 +928%
CS
43
Credit Suisse
Switzerland
$1.05M +$599K +6,275 +129%
Deutsche Bank
44
Deutsche Bank
Germany
$1.02M +$597K +6,254 +134%
PCM
45
Perkins Capital Management
Minnesota
$993K +$1.01M +10,580 New
NC
46
Northpointe Capital
Michigan
$955K -$702K -7,357 -42%
GP
47
Grow Partners
California
$939K +$954K +10,000 New
BIM
48
BlackRock Investment Management
Delaware
$903K -$11.3K -118 -1%
CCMH
49
Cornerstone Capital Management Holdings
New York
$772K +$360K +3,770 +85%
PAAMCP
50
Pacific Alternative Asset Management Company (PAAMCO)
California
$744K +$756K +7,923 New

PTX Hedge Fund Activity: Q4 2014 in Review

97 of the 3,749 institutional investors tracked by Wall St. Rank reported a position in Pernix Therapeutics Holdings, Inc. (PTX) for Q4 2014, worth a combined $310M — up 54% from $202M a quarter earlier.

Buyers outnumbered sellers: 26 funds opened new PTX positions and 10 closed out — a net gain of 16 holders — while 37 added to existing stakes and 23 trimmed.

The largest buyer was Kennedy Capital Management, adding an estimated $9.39M. The largest seller was Bank of Montreal, cutting an estimated $4.54M.

  • 97 institutional investors held Pernix Therapeutics Holdings, Inc. (PTX) as of Q4 2014, up from 83 in Q3 2014.
  • Funds reported $310M of Pernix Therapeutics Holdings, Inc. stock for Q4 2014, up 54% quarter-over-quarter.
  • 26 funds opened new Pernix Therapeutics Holdings, Inc. positions in Q4 2014 and 10 closed out, a net change of +16 holders.
  • The largest Pernix Therapeutics Holdings, Inc. buyer in Q4 2014 was Kennedy Capital Management, an estimated $9.39M added.
  • The largest Pernix Therapeutics Holdings, Inc. seller in Q4 2014 was Bank of Montreal, an estimated $4.54M sold.

Based on aggregated 13F filings for Q4 2014.